logo
Select company
Select metric
Ticker Information

Ticker

EXOZ

Company Name

EXOZYMES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

EXOZYMES INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

EXOZ - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -7.68M0%$ 0
3/31/2025$ -6.57M0%$ 0
12/31/2024$ -5.64M0%$ 0
9/30/2024$ -4.71M-6715.68%$ 70.07K
12/31/2023$ -1.79M-2552.65%$ 70.07K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for EXOZYMES INC is calculated as follows: EBITDA [ $ -1.79M ] / Revenues [ $ 70.07K ]
(=) EBITDA % [ -2552.65% ]

EXOZ - EBITDA Margin, Last 5 years

-6715.68%

Minimum

Sep 30, 2024

-2552.65%

Maximum

Dec 31, 2023

-4634.16%

Average

-4634.16%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%